id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0133-0012,FDA,FDA-2007-D-0133,"Chronic Obstructive Pulmonary Disease: Developing Drugs for
Treatment Guidance for Industry",Other,Guidance,2016-05-25T04:00:00Z,2016,5,2016-05-25T04:00:00Z,,2024-11-07T23:42:55Z,,1,0,0900006481fefb63
FDA-2007-D-0133-0011,FDA,FDA-2007-D-0133,Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2016-05-20T04:00:00Z,2016,5,2016-05-20T04:00:00Z,2016-07-20T03:59:59Z,2016-07-21T01:00:57Z,2016-11855,0,0,0900006481fe3c36